Sabrina Kuttruff-Coqui has joined AiCuris Anti-infective Cures AG as chief financial officer as the company progresses its pipeline of clinical and preclinical anti-viral and anti-bacterial product candidates. She succeeds Holger Schmoll. Dr Kuttruff-Coqui joins from Immatics NV where she was most recently head of business planning and portfolio strategy. She has also held senior positions at Immatics in risk management and translational development. Dr Kuttruff-Coqui holds a diploma in biochemistry from Eberhard-Karls-Universität Tübingen and Johann-Wolfgang-Goethe Universität Frankfurt, both in Germany. She earned a PhD in immunology from Eberhard-Karls-Universität Tübingen.
AiCuris announced the appointment on 1 September 2022.
Copyright 2022 Evernow Publishing Ltd